![]() |
|
|
GJ Wang, J Shan, PK Pang, MC Yang, CJ Chou and CF Chen
Department of Physiology, National Yang-Ming University, Taiwan, Republic of China.
We have examined both the hypotensive effect and the mechanism of intracellular Ca++ regulation, underlying rutaecarpine (Rut)-induced vasodilatation. An i.v. bolus injection of Rut in anesthetized Sprague- Dawley rats produced a dose-dependent hypotensive effect. In isolated rat aorta rings, Rut (0.1-3 mu M) inhibited the phasic and tonic responses of norepinephrine- and phyenylephrine-induced contractions, respectively, mainly through an endothelium-dependent mechanism. However, the vasorelaxing effect of Rut (3 microM) persisted in denuded aorta, although to a much less extent than in intact tissue. As determined by the fura-2/AM (1-[2-(5-carboxyoxazol-2-yl)-6- aminobenzofuran-5-oxy]-2-(2'- amino-5'-methylphenoxy)-ethane-N,N,N,N- tetraacetic acid pentaacetoxymethyl ester) method, Rut (10 microM), in the presence of extracellular Ca++, suppressed the KCI-induced increment in the intracellular Ca++ concentration ([Ca++]i) of cultured vascular smooth muscle cells (VSMC). Rut (10 microM) also attenuated the norepinephrine-induced peak rise of [Ca++]i in VSMC placed in Ca++- free solution. On the other hand, Rut (1 and 10 microM) increased the level of [Ca++]i of cultured endothelial cells (EC) in the presence of extracellular Ca++. In conclusion, Rut acts on both VSMC and EC directly. In VSMC, it reduces [Ca++]i through the inhibition of Ca++ influx and Ca++ release from intracellular stores. In EC, Rut augments EC [Ca++]i by increasing Ca++ influx, possibly leading to nitric oxide release. The paradoxical regulation of Ca++ in both VSMC and EC acts simultaneously to cause vasorelaxation which could account, at least in part, for the hypotensive action. This is a most significant and a unique feature of this study.
This article has been cited by other articles:
![]() |
D. Wu and Z. Hu Rutaecarpine Induces Chloride Secretion across Rat Isolated Distal Colon J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 256 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-J. Wang, A. Y.-C. Shum, Y.-L. Lin, J.-F. Liao, X.-C. Wu, J. Ren, and C.-F. Chen Calcium Channel Blockade in Vascular Smooth Muscle Cells: Major Hypotensive Mechanism of S-Petasin, a Hypotensive Sesquiterpene from Petasites formosanus J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 240 - 246. [Abstract] [Full Text] |
||||
![]() |
G.-J. Wang, X.-C. Wu, C.-F. Chen, L.-C. Lin, Y.-T. Huang, J. Shan, and P. K. T. Pang Vasorelaxing Action of Rutaecarpine: Effects of Rutaecarpine on Calcium Channel Activities in Vascular Endothelial and Smooth Muscle Cells J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1237 - 1244. [Abstract] [Full Text] |
||||
![]() |
H. Karaki, H. Ozaki, M. Hori, M. Mitsui-Saito, K.-I. Amano, K.-I. Harada, S. Miyamoto, H. Nakazawa, K.-J. Won, and K. Sato Calcium Movements, Distribution, and Functions in Smooth Muscle Pharmacol. Rev., June 1, 1997; 49(2): 157 - 230. [Abstract] [Full Text] [PDF] |
||||